🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Lymphangioleiomyomatosis

TSC Biosample Repository and Natural History Database NCT05676099n/a26 sites📍 Birmingham📍 Loma Linda📍 Los Angeles National Tuberous Sclerosis Association · Tests: Phlebotomy, Buccal (cheek) swab, Genetic Testing, Tissue donation after routine clinical procedure Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM) NCT06889168Phase 12 sites📍 New York📍 Charleston Columbia University · Tests: Imatimib Mesylate, Placebo The Genotype and Phenotype of Lymphangioleiomyomatosis NCT06405997n/a1 site📍 Taipei National Taiwan University Hospital Study of the Disease Process of Lymphangioleiomyomatosis NCT00001465n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: Toshibia Aquilion One CT Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis NCT01799538Phase 1, Phase 21 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: albuterol inhaler, albuterol nebulizer, PFT Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex NCT07304856n/a1 site📍 Milan University of Milan · Tests: Pulmonary Function Test, Analysis of Extracellular Vesicles National Lymphangioleiomyomatosis Registry, France NCT01484236n/a1 site📍 Lyon Vincent COTTIN Safety and Durability of Sirolimus for Treatment of LAM NCT02432560n/a20 sites📍 Stanford📍 Denver📍 Jacksonville University of Cincinnati · Tests: Sirolimus, Everolimus Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry) NCT06160310n/a1 site📍 Cincinnati David M. Ritter
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy